Efficacy and safety of telotristat ethyl in patients with carcinoid syndrome inadequately controlled by somatostatin analogs: Analysis of the completed TELESTAR extension period
Year: 2017
Type: conference-abstract
Source: Endocrine Abstracts
Authors: D Horsch, MH Kulke, M Caplin, L Anthony, E Bergsland, K Oberg, R Warner, P Kunz, E Grande Pulido, J Valle, J Dillon, P Lapuerta, P Banks, S Jackson, M Pavel
Institutions: Zentralklinik Bad Berka, Dana-Farber Cancer Institute, The Royal Free Hospital, University of Kentucky, Albert B. Chandler Hospital, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Uppsala University, Uppsala University Hospital, Icahn School of Medicine at Mount Sinai, Stanford Medicine, Hospital Universitario Ramón y Cajal, University of Manchester, The Christie Hospital, University of Iowa, Lexicon Pharmaceuticals (United States), Charité - Universitätsmedizin Berlin
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2791765701